Literature DB >> 32172272

Biosimilar pegfilgrastim and adherence to guidelines for chemotherapy-induced neutropenia and infections in cancer patients.

Marco Danova1, Andrea Antonuzzo2, Federico Spandonaro3, Paolo Pronzato4.   

Abstract

Not available.

Entities:  

Year:  2020        PMID： 32172272

Source DB:  PubMed          Journal:  Infez Med        ISSN： 1124-9390


× No keyword cloud information.
  1 in total

1.  Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer.

Authors:  Hsuan-Ming Yao; Sarah Ruta Jones; Serafin Morales; Shahrzad Moosavi; Jeffrey Zhang; Amy Freyman; Faith D Ottery
Journal:  Cancer Chemother Pharmacol       Date:  2021-10-07       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.